PhytoHealth Corporation — Investor Relations & Filings
PhytoHealth Corporation is a research-driven pharmaceutical company specializing in the development and commercialization of botanical new drugs. Utilizing a disease-targeted research model, the company translates historical clinical experiences with botanical medicine into modern therapeutic solutions. Its core portfolio includes PhytoHealth PG2®, an injectable treatment for cancer-related fatigue, and Naldebain®, an analgesic for moderate to severe acute pain. Beyond pharmaceutical development, the company leverages its expertise in astragalus extraction to produce specialized health supplements. PhytoHealth operates advanced manufacturing facilities compliant with PIC/S GMP standards, ensuring the quality and consistency of its phytomedicines. The company focuses on addressing unmet medical needs in oncology and pain management through innovative botanical science and rigorous clinical validation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告本公司115年第一季財務報告 董事會預計召開日期為115年5月8日 | 2026-04-30 | Chinese | |
| 115年4月公開說明書 — 202604_4108_B1c.pdf | 2026-04-20 | Chinese | |
| 115年4月公開說明書 — 200603_4108_B04.pdf | 2026-04-20 | Chinese | |
| 115年4月公開說明書 — 200601_4108_B011.pdf | 2026-04-20 | Chinese | |
| 115年4月公開說明書 — 200511_4108_B04.pdf | 2026-04-20 | Chinese | |
| 115年4月公開說明書 — 200506_4108_B04.pdf | 2026-04-20 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39970996 | 公告本公司115年第一季財務報告 董事會預計召開日期為115年5月8日 | 2026-04-30 | Chinese | ||
| 34692455 | 115年4月公開說明書 — 202604_4108_B1c.pdf | 2026-04-20 | Chinese | ||
| 34692454 | 115年4月公開說明書 — 200603_4108_B04.pdf | 2026-04-20 | Chinese | ||
| 34692453 | 115年4月公開說明書 — 200601_4108_B011.pdf | 2026-04-20 | Chinese | ||
| 34690927 | 115年4月公開說明書 — 200511_4108_B04.pdf | 2026-04-20 | Chinese | ||
| 34690926 | 115年4月公開說明書 — 200506_4108_B04.pdf | 2026-04-20 | Chinese | ||
| 34689190 | 115年4月公開說明書 — 200506_4108_B011.doc | 2026-04-20 | English | ||
| 33991914 | 115年3月背書保證與資金貸與 | 2026-04-10 | Chinese | ||
| 33989163 | 115年3月營業收入 | 2026-04-10 | Chinese | ||
| 33988386 | 114年第4季財務報告書 — 202504_4108_AIC.pdf | 2026-04-10 | English | ||
| 33988370 | 114年第4季財務報告書 — 202504_4108_AIA.pdf | 2026-04-10 | English | ||
| 33984863 | 114年第4季財務報告書 — 202504_4108_AI3.pdf | 2026-04-10 | Chinese | ||
| 33984852 | 114年第4季財務報告書 — 202504_4108_AI1.pdf | 2026-04-10 | Chinese | ||
| 33984846 | 114年第4季財務報告書 — 202503_4108_AIA.pdf | 2026-04-10 | English | ||
| 33984842 | 114年第4季財務報告書 — 202503_4108_AI1.pdf | 2026-04-10 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PhytoHealth Corporation via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52382/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52382 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52382 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52382 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52382}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PhytoHealth Corporation (id: 52382)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.